Loading the company…
Loading the company…
In 2025, Oticon Medical reported engagement with 36 surgeons and other clinicians in the states MedaRep covers, worth $8,300 in consulting, speaking, meals and travel for its device products, the most in Illinois ($1,276 to 2). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Illinois ($1,276, 2 engaged), Pennsylvania ($899, 2 engaged), Virginia ($787, 1 engaged), Arizona ($748, 5 engaged), Washington ($716, 3 engaged).
In the last ten years FDA made 14 decisions for Oticon Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2021 (9). The latest was on 2022-11-04.
| Family | Decisions on record |
|---|---|
| Cochlear implants | 14 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2022-11-04 | PMA | P200021-S013 | Neuro Cochlear Implant System (NCIS) · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2022-06-17 | PMA | P200021-S014 | Neuro Cochlear Implant System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2022-05-27 | PMA | P200021-S012 | Neuro Cochlear Implant System (NCIS) · Postapproval Study Protocol |
| 2022-03-15 | PMA | P200021-S011 | Neuro Cochlear Implant System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2022-01-14 | PMA | P200021-S010 | Neuro Cochlear Implant System · Postapproval Study Protocol |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Oticon Medical.